These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
810 related articles for article (PubMed ID: 15698480)
1. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. Wofford JL; Ohl CA BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480 [TBL] [Abstract][Full Text] [Related]
2. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279 [TBL] [Abstract][Full Text] [Related]
3. Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential. Sarikaya O; Civaner M; Vatansever K Adv Health Sci Educ Theory Pract; 2009 Dec; 14(5):713-24. PubMed ID: 19184498 [TBL] [Abstract][Full Text] [Related]
4. Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: a multi-institutional study. Kao AC; Braddock C; Clay M; Elliott D; Epstein SK; Filstead W; Hotze T; May W; Reenan J Acad Med; 2011 Nov; 86(11):1454-62. PubMed ID: 21952057 [TBL] [Abstract][Full Text] [Related]
5. Medical student views on interactions with pharmaceutical representatives. Ganzini L; Chen Z; Peters D; Misra S; Macht M; Osborne M; Keepers G Acad Psychiatry; 2012 May; 36(3):183-7. PubMed ID: 22751818 [TBL] [Abstract][Full Text] [Related]
6. Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry. Hyman PL; Hochman ME; Shaw JG; Steinman MA Acad Med; 2007 Jan; 82(1):94-9. PubMed ID: 17198299 [TBL] [Abstract][Full Text] [Related]
7. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. Hodges B CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153 [TBL] [Abstract][Full Text] [Related]
8. Medical student exposure to and attitudes about pharmaceutical companies. Soyk C; Pfefferkorn B; McBride P; Rieselbach R WMJ; 2010 Jun; 109(3):142-8. PubMed ID: 20672554 [TBL] [Abstract][Full Text] [Related]
9. The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products. Sandberg WS; Carlos R; Sandberg EH; Roizen MF Acad Med; 1997 Oct; 72(10):916-8. PubMed ID: 9347716 [TBL] [Abstract][Full Text] [Related]
10. Relationships between drug company representatives and medical students: medical school policies and attitudes of student affairs deans and third-year medical students. Sierles F; Brodkey A; Cleary L; McCurdy FA; Mintz M; Frank J; Lynn DJ; Chao J; Morgenstern B; Shore W; Woodard J Acad Psychiatry; 2009; 33(6):478-83. PubMed ID: 19933893 [TBL] [Abstract][Full Text] [Related]
11. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Brett AS; Burr W; Moloo J Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219 [TBL] [Abstract][Full Text] [Related]
12. A national survey on the effect of pharmaceutical promotion on medical students. Vainiomäki M; Helve O; Vuorenkoski L Med Teach; 2004 Nov; 26(7):630-4. PubMed ID: 15763854 [TBL] [Abstract][Full Text] [Related]
13. [Is it pertinent to investigate the relations between physicians and the drug industry]. Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930 [TBL] [Abstract][Full Text] [Related]
14. Drug representatives: giving you lunch or stealing your soul? Higgins SP Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002 [TBL] [Abstract][Full Text] [Related]
15. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Halperin EC; Hutchison P; Barrier RC Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735 [TBL] [Abstract][Full Text] [Related]
16. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry]. Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378 [TBL] [Abstract][Full Text] [Related]
17. Medical students' exposure to and attitudes about drug company interactions: a national survey. Sierles FS; Brodkey AC; Cleary LM; McCurdy FA; Mintz M; Frank J; Lynn DJ; Chao J; Morgenstern BZ; Shore W; Woodard JL JAMA; 2005 Sep; 294(9):1034-42. PubMed ID: 16145023 [TBL] [Abstract][Full Text] [Related]
18. Effect of legislative changes in drug promotion on medical students: questionnaire survey. Vuorenkoski L; Valta M; Helve O Med Educ; 2008 Dec; 42(12):1172-7. PubMed ID: 19120947 [TBL] [Abstract][Full Text] [Related]
19. Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors. Lichstein PR; Turner RC; O'Brien K Arch Intern Med; 1992 May; 152(5):1009-13. PubMed ID: 1580704 [TBL] [Abstract][Full Text] [Related]
20. Changes in medical students' exposure to and attitudes about drug company interactions from 2003 to 2012: a multi-institutional follow-up survey. Sierles FS; Kessler KH; Mintz M; Beck G; Starr S; Lynn DJ; Chao J; Cleary LM; Shore W; Stengel TL; Brodkey AC Acad Med; 2015 Aug; 90(8):1137-46. PubMed ID: 25785675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]